News

MeiraGTx Acquires Rights to AAV-AQP1 Gene Therapy for Sjögren’s Syndrome

MeiraGTx recently acquired global rights over an investigational gene therapy called AAV-AQP1 being developed to treat the excessive dry mouth and eyes experienced by patients with Sjögren’s syndrome. The announcement comes after an exclusive licensing agreement with the National Institute of Dental and Craniofacial Research (NIDCR), an arm of the …

Dental Implants Provide Relief from Oral Inflammation in Sjögren’s Patient, Case Report Shows

Dental implants with fitted crowns provided comfort and relieved inflammation in a Sjögren’s syndrome patient experiencing discomfort with removable dentures, according to a case report from dental surgeons in Japan. The report, “Implant-supported Prostheses in Patient with Sjögren’s Syndrome: Clinical Report with 3-year Follow-up,” was published in the…